Shay Capital’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Shay Capital’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-50,000	Closed	-$120K	–	436
2024 Q2	$120K	Hold	50,000	–	–	0.02%	233
2024 Q1	$246K	Hold	50,000	–	–	0.04%	277
2023 Q4	$209K	Buy	+50,000	New	+$377K	0.04%	199

Other funds holding ASLN

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Shay Capital's ASLN Position: Q3 2024 in Review

Shay Capital sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q3 2024, closing a stake of 50,000 shares — an estimated $120K sold.

Shay Capital first reported a position in ASLN in Q4 2023 and held it in 3 quarters. The position peaked at $246K in Q1 2024. 1 fund tracked by Wall St. Rank holds ASLN as of Q3 2024.

Shay Capital reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q3 2024 after selling out during the quarter.
Shay Capital sold 50,000 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q3 2024, an estimated $120K.
Shay Capital first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q4 2023 and held it in 3 quarters.
Shay Capital's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $246K in Q1 2024.
1 fund tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q3 2024.

Based on Shay Capital's 13F filing for Q3 2024, filed 14 Nov 2024.